Dr. Ethan Craig Picks His Favorite Gout Abstracts from ACR Convergence 2020

[Back to the Resource Center.]

Keri Losavio is the staff editor of The Rheumatologist.

References

1. White WB, Saag KG, Becker MA, et al. Cardiovascular safety of febuxostat or allopurinol in patients with gout. N Engl J Med. 2018 Mar 29;378(13):1200–1210.
2. MacDonald T, Mackenzie I, Nuki G, Ford I. Long term cardiovascular safety of febuxostat and allopurinol in patients with chronic gout: The febuxostat versus allopurinol streamlined trial (on Behalf of the FAST Investigators) [abstract]. Arthritis Rheumatol. 2020 Oct;72(suppl 10).